Skip to Main Content

Paper Details

Aducanumab produced a clinically meaningful benefit in association with amyloid lowering.
Alzheimers Res Ther
119
2021
Author NameAffiliation
Paul S AisenUniversity of Southern California
Cynthia A LemereAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School
Marwan N SabbaghCleveland Clinic Lou Ruvo Center for Brain Health
Stephen SallowayButler Hospital and Brown University
  • 1 - 4

Datasets

Release 1.2